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eosinophilia by co-exposure to contamination
levels of LPS in Asian sand dust and heated dust
Yahao Ren1, Takamichi Ichinose2*, Miao He3, Yuan Song4, Yasuhiro Yoshida4, Seiichi Yoshida2, Masataka Nishikawa5,
Hirohisa Takano6, Guifan Sun3* and Takayuki Shibamoto7Abstract
Background: A previous study has shown that the aggravation of Asian sand dust (ASD) on ovalbumin (OVA)-induced
lung eosinphilia was more severe in lipopolysaccharide (LPS)-rich ASD than in SiO2-rich ASD. Therefore, the effects
of different LPS contamination levels in ASD on the aggravation of OVA-induced lung eosinophilia were
investigated in the present study.
Methods: Before beginning the in vivo experiment, we investigated whether the ultra-pure LPS would act only on
TLR4 or not using bone marrow-derived macrophages (BMDMs) of wild–type, TLR2−/−, TLR4−/− and MyD88−/−
BALB/c mice. ASD collected from the desert was heated to remove toxic organic substances (H-ASD). BALB/c mice
were instilled intratracheally with 12 different testing samples prepared with LPS (1 ng and 10 ng), H-ASD, and
OVA in a normal saline solution. The lung pathology, cytological profiles in the bronchoalveolar lavage fluid (BALF),
the levels of inflammatory cytokines/chemokines in BALF and OVA-specific immunoglobulin in serum were
investigated.
Results: The LPS exhibited no response to the production of TNF-α and IL-6 in BMDMs from TLR4−/−, but did
from TLR2−/−. H-ASD aggravated the LPS-induced neutrophilic lung inflammation. In the presence of OVA, LPS
increased the level of eosinophils slightly and induced trace levels of Th2 cytokines IL-5 and IL-13 at the levels of
1 ng and 10 ng. In the presence of OVA and H-ASD, LPS induced severe eosinophil infiltration and proliferation of
goblet cells in the airways as well as remarkable increases in Th2 cytokines IL-5 and IL-13 in BALF. The mixture
containing LPS (1 ng) showed adjuvant activity on OVA-specific IgE and IgG1 production.
Conclusions: The results suggest that H-ASD with naturally-occurring levels of LPS enhances OVA-induced lung
eosinophilia via increases in Th2-mediated cytokines and antigen-specific immunoglobulin. These results indicate
that LPS is a strong candidate for being a major aggravating substance in ASD.
Keywords: Lipopolysaccharide, Asian sand dust, Ovalbumin, Lung eosinophilia, Cytokine and chemokine, AsthmaBackground
Asian sand dust (ASD) is observed most frequently in the
spring. When a large scale sandstorm occurs in Northern
China and Mongolia, ASD aerosol spreads over large
areas, including East China, the Korean Peninsula and
Japan as well as crossing the North Pacific to the United* Correspondence: ichinose@oita-nhs.ac.jp; sungf@mail.cmu.edu.cn
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Dedication waiver (http://creativecommons.or
unless otherwise stated.States [1-3]. In recent years, ASD has received more and
more attention as the adverse effects on human health be-
come known. Epidemiological studies suggested that ASD
events may be associated with increased death rates due
to respiratory and circulatory diseases [4,5]. Some reports
also suggest that ASD events are associated with increased
respiratory symptoms in both adults and children with
asthma [6,7].
Our previous studies have shown that ASD had aggra-
vating effects on ovalbumin (OVA) - induced lung eosino-
philia, whereas ASD heated at 360°C to exclude organic. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[8,9]. On the basis of these results, we speculate that the
organic substances and chemicals adhering to ASD may
contribute to the aggravation of lung eosinophila. Micro-
bial and by-product materials derived from air-pollutants,
including polycyclic aromatic hydrocarbons (PAHs), sul-
fates ðSO2−4 Þ and nitrates ðNO−3Þ, adhere onto ASD during
long-range transportation of the dust [10-12]. ASD was
contaminated with trace levels of LPS, which is a cell wall
component of gram-negative bacteria. Epidemiological
studies suggest that endotoxin levels in samples from chil-
dren’s mattress were inversely related to the occurrence of
atopic asthma [13]. On the other hand, some other studies
have shown that endotoxin exposure is positively associ-
ated with an increased risk of asthma and asthma severity
in both adults and children [14,15]. The results of animal
studies are also somewhat contradictory. Interestingly,
some studies suggest that LPS at a low dose facilitates a
Th2 response to allergens, while LPS at a high dose favors
Th1 inflammation [16,17]. Our recent study has shown
that the aggravation of murine lung eosinophilia was more
severe in LPS-rich ASD than in SiO2-rich ASD [18].
Therefore, experimental study as to whether the levels of
LPS contamination in ASD are significantly related to the
degree of aggravation of the lung eosinophilia is in order.
In the present study, the exacerbating effects of low
levels of LPS and/or H-ASD on OVA-induced lung eo-
sinophilia were investigated using BALB/c mice.Materials and methods
Animals
Specific pathogen-free male BALB/c mice (6 weeks of age)
were obtained from Charles River Japan, Inc. (Kanagawa,
Japan). The body weight of the mice and the presence of
infection were checked for 1 week. The mice used were
7 weeks of age. CE-2 commercial diet (CLEA Japan, Tokyo,
Japan) and water were given ad libitum. The mice were
housed in plastic cages lined with soft wood chips. The
cages were placed in a conventional room, which was air
conditioned at 23°C with a light/dark (12 h/12 h) cycle, and
humidity ranging from 55 to 70%. The study adhered to
the US National Institutes of Health guidelines for the use
of experimental animals. The animal care method was also
approved by the animal care and use committee at Oita
University of Nursing and Health Sciences in Oita, Japan.Preparation of particles and LPS
The Asian dust used as the standard base for the samples
in this study was collected from surface soils in the Gobi
desert and purified for use in the present study. The size
distribution peak was observed at 3.9 μm. The chemical
elements in ASD were as reported previously: 51.6% SiO2,
14.3% Al2O3, 5.5% Fe2O3, 1.3% Na2O, 9.6% CaCO3, 0.6%CaO, 2.5% MgO, 0.7% TiO2 and 2.6% K2O. And, as in the
previous study, 11.3% of total oxides were lost at ig [19]. A
portion of the standard ASD was heated at 360°C for
30 min in an electric heater to exclude toxic materials
(sulfate, nitrate, microorganism, etc.). These samples are
termed H-ASD in the present study. Ultra pure LPS was
purchased from InvivoGen (San Diego, CA, USA).
Study protocol
One hundred and sixty eight BALB/c mice were divided
into twelve groups (n = 14 per group) and each group
was treated with a specific testing sample. The 12 testing
samples (0.1 mL each of 0.9% NaCl normal saline solu-
tion) prepared for the present study were control (con-
taining normal saline alone); H-ASD (0.1 mg H-ASD
alone); LPS 1 (1 ng LPS alone); LPS 10 (10 ng LPS
alone); H-ASD + LPS 1 (0.1 mg H-ASD and 1 ng LPS);
H-ASD + LPS 10 (0.1 mg H-ASD and 10 ng LPS); OVA
(2 μg OVA alone); OVA + H-ASD (2 μg OVA and
0.1 mg H-ASD); OVA + LPS 1 (2 μg OVA and 1 ng
LPS); OVA + LPS 10 (2 μg OVA and 10 ng LPS); OVA +
H-ASD + LPS 1 (2 μg OVA, 0.1 mg H-ASD, and 1 ng
LPS); and OVA +H-ASD + LPS 10 (2 μg OVA, 0.1 mg
H-ASD, and 10 ng LPS). The mice were intratracheally
challenged with a mixed or individual solution of OVA,
H-ASD and LPS 4 times at 2-week intervals. The con-
trol group was instilled intratracheally with 0.1 ml nor-
mal saline.
Bronchoalveolar lavage fluid (BALF)
Eight out of 14 mice were used for an examination of the
free cell contents in BALF. BALF and cell counts were
conducted using a previously reported method [18,20].
Briefly, the lungs were lavaged with two injections of
0.8 ml of sterile saline at 37°C. After the fluids from the
two lavages were combined and cooled to 4°C, the result-
ant solution was centrifuged at 1500 rpm for 10 min. The
protein levels of cytokines and chemokines in the BALF
were measured. The total cell count of the fresh fluid spe-
cimen was determined by a hemocytometer. Differential
cell counts were assessed on cytological preparations.
Slides were prepared using a Cytospin (Sakura Co., Ltd,
Tokyo, Japan) and stained with Diff-Quik (International
Reagents Co., Kobe, Japan) to identify the eosinophils with
red granules. A total of 300 cells were counted under a
microscope. The BALF supernatants were stored at −80°C
to await analysis for cytokines and chemokines.
Pathological evaluation
The remaining 6 mice in each group were used for patho-
logical examination. The lungs were fixed by 10% neutral
phosphate-buffered formalin. After separation of the lobes,
2-mm-thick blocks were taken for paraffin embedding.
Embedded blocks were sectioned at a thickness of 3 μm,
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evaluate the degree of infiltration of eosinophils and
lymphocytes in the airway from proximal to distal. The
sections were stained with periodic acid-Schiff (PAS) to
evaluate the degree of proliferation of goblet cells in the
bronchial epithelium. A pathological analysis of inflam-
matory cells and epithelial cells in the airway was per-
formed using a Nikon ECLIPSE light microscope
(Nikon Co., Tokyo, Japan). The degree of infiltration of
eosinophils and lymphocytes in the airway or prolifera-
tion of goblet cells in the bronchial epithelium was
graded in a blinded fashion: 0, not present; 1, slight; 2,
mild; 3, moderate; 4, moderate to marked; 5, marked.
‘Slight’ was defined as less than 20% of the airway with
eosinophilic inflammatory reaction or with goblet cells
stained with PAS; ‘mild’ as 21 - 40%; ‘moderate’ as 41 -
60%; ‘moderate to marked’ as 61 - 80%; and marked as
more than 80% of the airway [18,20].
Quantitation of cytokines and chemokines in BALF
The cytokine and chemokine protein levels were deter-
mined by enzyme-linked immunosorbent assays (ELISA).
IL-5 and IL-12 were measured using an ELISA kit from
Endogen, Inc. (Cambridge, MA, USA). MCP-3 was mea-
sured using an ELISA kit from Bender MedSystems Inc.0
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Figure 1 Cytokine and chemokine production in LPS-stimulated BMD
concentration of 1 μg/ml) for 12 h. The cytokine levels secreted into the cu
expressed as mean ± SE (n = 6). *p < 0.001 vs. WT; †p < 0.001 vs. TLR2−/−.(Burlingame, CA, USA). IL-1β, IL-4, IL-6, IL-13, IL-17A,
IFN-γ, KC, TNF-α, TGF-β, Eotaxin, MCP-1, MIP-1α,
RANTES were measured using an ELISA kit from R&D
Systems Inc. (Minneapolis, MN, USA).
OVA-specific IgE and IgG1 antibodies
OVA-specific immunoglobulin E (IgE) and IgG1 anti-
bodies were measured using the Mouse OVA-IgE
ELISA kit and Mouse OVA-IgG1 ELISA kit (Shibayagi
Co., Shibukawa, Japan). According to the manufacturer’s
protocol, 1U of the anti-OVA IgE is defined as 1.3 ng of
the antibody; and 1U of the anti-OVA IgG1 is defined as
160 ng of the antibody. The absorption of 450 nm (sub-
wave length, 620 nm) for OVA-specific IgE and IgG1 anti-
body was measured by a microplate reader (Spectrafluor,
Tecan, Salzburg, Austria).
Isolation and culture of murine bone marrow-derived
macrophages (BMDMs)
Wild–type, TLR2−/−, TLR4−/− and MyD88−/− mice
(on BALB/c background) were purchased from Oriental
Bioservice, Inc (Kyoto, Japan). Femurs were removed at
8 weeks of age, the soft tissue removed, and flushed
with Hanks to recover the bone marrow. BMDMs were
cultured on plastic dishes in RPMI (Nissui, Tokyo,0
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Ms of KO mice. BMDMs were incubated with PBS, LPS (final
lture medium from BMDMs were measured by ELISA. All values were
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York, NY) and 10% inactivated fetal bovine serum
(Thermo Scientific, South Logan, UT). 10 ng/ml of
GM-CSF (PeproTech EC, London, UK) was added to
the culture on days 0 and 3. After 6 days in culture, the
adherent BMDMs were collected by adding 0.02% 5 ml
EDTA and then scraping the loose cells off. Then BMDMs
were re-plated at a concentration of 3 × 105 cells/ml into
24-well plates at 1 ml/well. BMDMs were incubated with
PBS or LPS (final 1 μg/ml) for 12 h. Cytokines secreted
into the culture medium by BMDMs were measured by
ELISA.
Assay for cytokines and chemokines in cell culture
medium
The protein levels of cytokines and chemokines in
the nutrient medium were determined by ELISA. IL-6,
MCP-1, MIP-1α, and TNF-α were measured using ELISA
kits from R&D Systems Inc.
Statistical analysis
Statistical analysis on the pathological evaluation in the
airway, cytokines, and chemokine proteins in BALF were
conducted using the Tukey Test for Pairwise Comparisons*
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Figure 2 Cellular profile in bronchoalveolar lavage fluids (BALF). All v
LPS 1; ‡p < 0.05 vs. LPS 10; §p < 0.05 vs. H-ASD; &p < 0.05 vs. H-ASD + LPS 1
LPS 1; βp < 0.05 vs. OVA + LPS 10; γp < 0.05 vs. H-ASD + OVA; £p < 0.05 vs. H(KyPlot Ver 5.0, Kyens Lab Inc, Tokyo, Japan). Differences
among groups were determined as statistically significant
at a level of p < 0.05.
Results
Cytokines and chemokines in cell culture medium from
mice treated by LPS
Figure 1 shows the amounts of cytokine and chemo-
kine produced in LPS-stimulated BMDMs of KO mice.
Relatively high levels of IL-6, MCP-1, MIP-1α and TNF-α
were found in WT cells, ranging from 136 ± 19.4 pg/ml
(MIP-1α) to 2,080 ± 297 pg/ml (IL-6), and TLR2−/− cells,
ranging from 96.0 ± 16.0 pg/ml (MIP-1α) to 1,763 ±
223 pg/ml (IL-6). Trace levels of MIP-1α (5.57 ±
1.20 pg/ml) and TNF-α (10.4 ± 10.4 pg/ml) were observed
in MyD88−/− cells, and they reduced significantly com-
pared with WT cells. On the other hand, IL-6 and TNF-α
were not detected in TLR4−/− cells. IL-6 was also not
detected in MyD88−/− cells.
The cell numbers in BALF from mice treated by OVA,
H-ASD and LPS
Figure 2 shows the cellular profiles in BALF. The total
cell numbers ranged from (12.8 ± 1.92) × 104 (control) to*†§
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-ASD + OVA + LPS 1.
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http://www.aacijournal.com/content/10/1/30(113 ± 9.33) × 104 (H-ASD + OVA + LPS 10). The cell
numbers in the control samples ranged from 0 (eosino-
phils) to (12.6 ± 1.89) × 104 (macrophages). LPS 1 and LPS
10 increased the number of macrophages by 168% and
137%, respectively. The addition of H-ASD to LPS 1 and
LPS 10 increased macrophages, netrophils and lympho-
cytes significantly, whereas no change was observed in eo-
sinophils. OVA alone did not increase any cell numbers
but the addition of LPS 1 and LPS 10 increased all cell
numbers in BALF samples slightly. When LPS 1 +H-ASD
and LPS 10 +H-ASD were added to OVA, a significant in-
crease of numbers of all cells was observed. The increase
was dose dependent in macrophages and neutrophils but
not in eosinophils and lymphocytes.
Cellular changes in the airways of mice treated by OVA,
H-ASD and LPS
Figure 3 shows the cellular changes caused by H-ASD
and LPS in the murine airway. The pathological score
ranged from 0 (eosinophils) to 3.42 ± 0.15 (lymphocytes).
When the control, LPS 1, LPS 10, H-ASD and H-ASD +
LPS 1 samples were exposed, a moderate increase in*‡α¶
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Figure 3 Evaluation of cellular changes in the murine airway. The deg
(1) slight; (2) mild; (3) moderate; (4) moderate to marked; (5) marked. All va
conducted using Tukey for Pairwise Comparisons. *p < 0.05 vs. control; †p <
H-ASD + LPS 1; #p < 0.05 vs. H-ASD + LPS 10; αp < 0.05 vs. OVA; ¶p < 0.05 vlymphocytes, ranging from 0.25 ± 0.11 (LPS 1) to 0.58 ±
0.08 (H-ASD + LPS 1), was observed along with a slight
increase of goblet cells ranging from 0.17 ± 0.11 (LPS 1,
LPS 10, H-ASD) to 0.25 ± 0.11 (H-ASD + LPS 1). Eosi-
nopils were not detected. When H-ASD + LPS 10, OVA,
OVA + LPS 1, OVA + LPS 10 and H-ASD + OVA were
exposed, moderate increases of all cells ranged from
0.25 ± 0.11 (eosinophils) to 1.67 ± 0.25 (goblet cells) oc-
curred. The samples exposed to H-ASD + OVA + LPS 1
and H-ASD + OVA + LPS 10 showed a significant in-
crease in goblet cells (3.25 ± 0.11 and 2.75 ± 021, respect-
ively) eosinophils (2.92 ± 0.15 and 2.50 ± 0.18, respectively)
and lymphocytes (3.42 ± 0.15 and 3.08 ± 0.20, respectively)
in the submucosa of the airway. It is interesting that the
pathological change was greater with low dose (1 ng)
addition of LPS than by with 10 ng LPS.
Figures 4 and 5 illustrate the effects of LPS on patho-
logical changes in the lungs. No pathological alterations
were found in the lungs of the control group. LPS 1 and
LPS 10 caused slight infiltration of neutrophils in the
submucosa of the airway, while H-ASD + LPS 1 and H-
ASD + LPS 10 caused slight proliferation of goblet cells* *
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lues were expressed as mean ± SE (n = 6). Statistical analyses were
0.05 vs. LPS 1; ‡p < 0.05 vs. LPS 10; §p < 0.05 vs. H-ASD; &p < 0.05 vs.
s. OVA + LPS 1; βp < 0.05 vs. OVA + LPS 10; γp < 0.05 vs. H-ASD + OVA.
Figure 4 Effects of test samples on pathological changes in the lungs. No pathologic alterations were seen in the lungs of the control (A).
Slight bronchitis with slight proliferation of goblet cells that have mucus stained pink with PAS was seen in airway epithelium and slight
infiltration of inflammatory cells in the submucosa of airways exposed to H-ASD + LPS 1 (B). Bronchitis with slight proliferation of goblet cells
and moderate infiltration of inflammatory cells such as neutrophils and lymphocytes were seen in the submucosa of airways exposed to
H-ASD + LPS 10 (C). Very slight proliferation of goblet cells in the airway epithelium and very slight infiltration of inflammatory cells such as
lymphocytes were seen in the submucosa of airways exposed to OVA alone (D). The pathological alteration in the airway epithelium and the
submucosa of airways exposed to OVA + LPS 1 (E) were almost the same. The pathological changes exposed to OVA + LPS 10 (F) were
somewhat stronger than those of OVA + LPS 1. Slight goblet cell proliferation and mild infiltration of inflammatory cells were found in the
submucosa of airways exposed to H-ASD + OVA (G). Moderate goblet cell proliferation, accumulation of numerous inflammatory cells in the
submucosa of airway, and fibrous thickening of the subepithelial layer were seen in the airways exposed to H-ASD + OVA + LPS 1 (H) and
moderate goblet cell proliferation, severe infiltration of inflammatory cells in the submucosa of airways exposed to H-ASD + OVA + LPS 10 (I).
(A–I) PAS stain; bar = 50 μm.
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to moderate infiltration of neutrophils in the airway
(Figure 5B and C). OVA alone caused a slight prolifera-
tion of goblet cells in the airway epithelium (Figure 4D) as
well as eosinophils, neutrophils and lymphocytes in the
submucosa of airway (Figure 5D).
The pathological alteration in the airway epithelium
and the submucosa of airways exposed to OVA alone
and OVA + LPS 1 were almost the same (Figure 4D, F;
Figure 5D, F). However, the pathological changes in sam-
ples exposed to OVA + LPS 10 were somewhat higherthan those exposed to OVA + LPS 1 (Figure 4E and F).
H-ASD + OVA also caused slight goblet cell proliferation
and slight infiltration of eosinophils and lymphocytes in
the submucosa of airway. However, H-ASD + OVA + LPS
1 and H-ASD + OVA + LPS 10 caused moderate goblet
cell proliferation in the airway epithelium (Figure 4H
and I) and moderate to marked accumulation of eosino-
phils, neutrophils and lymphocytes in the submucosa of
airways (Figure 5H and I). These pathological alterations
in the H-ASD + OVA + LPS 1 group were more severe
than in the H-ASD + OVA + LPS 10 group.
Figure 5 Effects of test samples on infiltration of inflammatory cells in the airway. No pathologic changes in the lungs of the control (A).
Mild infiltration of neutrophils and lymphocytes in the submucosa of airways exposed to H-ASD + LPS 1 (B). Moderate infiltration of neutrophils
and lymphocytes in the submucosa of airways exposed to H-ASD + LPS 10 (C). Slight eosinophils, neutrophils and lymphocytes in the submucosa
of airways exposed to OVA alone (D). Mild to moderate infiltration of the inflammatory cells in the submucosa of airways exposed to OVA + LPS 1
(E) and OVA + LPS 10 (F). Slight infiltration of inflammatory cells in the submucosa of airways exposed to H-ASD + OVA (G). Severe accumulation of
eosinophils, neutrophils and lymphocytes in the submucosa of airways exposed to H-ASD + OVA + LPS 1 (H). Moderate to marked infiltration of
eosinophils, neutrophils and lymphocytes in the submucosa of airways exposed to H-ASD + OVA + LPS 1 (I) (A–I) HE stain; bar = 20 μm.
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mice treated by OVA, H-ASD and LPS
Figure 6 shows the levels of IL-12, KC, MCP-1 and
RANTES in BALF. The protein levels in the control
ranged from not detected (IL-12) to 22.8 ± 1.27 pg/ml
(KC). LPS 1 alone did not significantly increase the pro-
teins examined, whereas LPS 10 increased them appre-
ciably, to levels ranging from 5.14 ± 1.28 pg/ml (MCP-1)
to 145 ± 32.5 pg/ml (IL-12). H-ASD increased IL-12,
KC, and MCP-1. H-ASD + LPS increased all proteins.
In particular, the addition of LPS 10 to H-ASD in-
creased IL-12 by 99% and RANTES by 1179%. The
amount of proteins found in the samples treated with
OVA alone ranged from 1.39 ± 0.52 pg/ml (MCP-1) to
25.8 ± 4.17 (KC). The addition of LPS to OVA showed a
dose-dependent increase in all proteins. When LPS wasadded to an OVA + H-ASD sample, all proteins also
showed a dose-dependent increase.
Figure 7 shows the expression of IL-1β, IL-6, MIP-1α
and TNF-α. The protein levels in the control samples
ranged from not detected (TNF-α) to 7.82 ± 3.17 pg/ml
(IL-1β). LPS increased all proteins dose-dependently.
H-ASD increased but OVA reduced all proteins. H-ASD
alone increased IL-1β significantly, by 218%. Addition
of LPS 10 to H-ASD increased IL-6 by 327% but LPS 1
reduced IL-6 slightly (by 11%). The amount of proteins
found in samples treated by OVA ranged from 0 (TNF-α)
to 2.31 ± 0.51 pg/ml (IL-1β). Addition of LPS 10 to
OVA increased IL-1β from 2.31 ± 0.51 pg/ml to 5.92 ±
0.82 pg/ml, whereas addition of LPS 1 to OVA decreased
it to 1.79 ± 0.44 pg/ml. Addition of LPS to H-ASD + OVA
dose-dependently increased all proteins considerably. The
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Figure 6 Expressions of MCP-1, KC, IL-12 and RANTES in BALF. All values were expressed as mean ± SE (n = 8). *p < 0.05 vs. control; †p < 0.05
vs. LPS 1; ‡p < 0.05 vs. LPS 10; §p < 0.05 vs. H-ASD; &p < 0.05 vs. H-ASD + LPS 1; #p < 0.05 vs. H-ASD + LPS 10; αp < 0.05 vs. OVA; ¶p < 0.05 vs. OVA
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the highest levels of all proteins, ranging from 12.3 ±
2.3 pg/ml (TNF-α) to 29.2 ± 4.31 pg/ml (MIP-1α).
Figure 8 shows the expression of IL-5, IL-13, eotaxin
and MCP-3 in BALF. These proteins are known as al-
lergy associated mediators. The amount in the control
group of samples ranged from not detected (IL-13) to
6.76 ± 0.94 pg/ml (MCP-3). Among the proteins in this
group, MCP-3 was detected in the highest levels in all
samples from treated mice except one set of sample from
H-ASD treatment, ranging from not detected (H-ASD) to
65.3 ± 16.3 pg/ml (H-ASD + OVA + LPS 10). When LPS
was added to H-ASD, slight, dose-dependent increases of
all proteins were observed.
A slight increase of all proteins was observed in the
samples treated by OVA alone, ranging from 1.14 ±
0.38 pg/ml (IL-13) to 10.8 ± 0.87 pg/ml (MCP-3). Addition
of LPS to OVA increased IL-5 significantly but the other
samples increased only slightly. Addition of H-ASD to
OVA increased IL-5 considerably from 1.68 ± 0.51 pg/ml
to 21.5 ± 6.78 pg/ml. The addition of LPS to OVA + H-
ASD triggered a remarkable increase in all proteins.
However, the increasing levels of IL-5 and IL-13 in thegroup treated with LPS 1 (448% and 302%, respectively)
were higher than those of the group treated with LPS 10
(211% and 133%, respectively).
Figure 9 shows the expression of IL-4 and IL-17A.
They were not detected in the samples of the control,
LPS 1, LPS 10, or H-ASD groups. The amounts of IL-4
ranged from not detected to 2.55 ± 1.52 pg/ml (H-ASD +
OVA + LPS 1) and IL-17A ranged from not detected to
14.6 ± 5.14 (H-ASD + OVA + LPS 10). IL-4 and IL-17A
were not present in significant amounts in the samples
treated with H-ASD + LPS 1, OVA, OVA + LPS 1 and
H-ASD + OVA but H-ASD and LPS obviously increased
both proteins.
In the present study, TGF-β and IFN-γ were not
detected.
Enhancement of OVA-specific IgE and IgG1 by H-ASD and
LPS
Figure 10 shows the effects of testing samples on IgE
and IgG1 production in serum. IgE and IgG1 were not
detected in the samples of the control, LPS 1, LPS 10,
H-ASD, H-ASD + LPS 1 or H-ASD + LPS 10 samples.
Trace levels of IgE were observed in OVA but not IgG1.
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to similar levels of OVA-specific IgE. H-ASD + OVA +
LPS 1 increased the level of the IgE and IgG1 in serum
most effectively.
Discussion
Exposure to LPS is known to be a significant risk factor
for increased asthma prevalence and severity [21,22].
Therefore, LPS contaminated ASD may cause aggravation
of allergic lung inflammation. Previous reports have dem-
onstrated that co-treatment of TLR2-ligand Pam3Cys and
OVA activated an OVA-associated Th2-biased immune
response in experimental asthma [23]. Therefore, ultra-
pure LPS was used in this study because the LPS made
commercially is contaminated with TLR2-ligands. Before
beginning the in vivo experiment, we investigated whether
our ultra-pure LPS would act only on TLR4 or not using
BMDMs of WT, TLR2 KO, TLR 4 KO and MyD88 KO
mice. As shown in Figure 1, this LPS exhibited no re-
sponse to the production of cytokines (TNF-α and IL-6)
in BMDMs from TLR4 KO, but from TLR2 KO.
Previous studies have reported that LPS inhaled in
low levels (0.1 μg) enhanced Th2 responses to inhaled
OVA in a mouse model of Th2 pulmonary inflammation,while inhalation of high levels (10 μg, 100 μg) of LPS with
an antigen caused a Th1 response [16,17].
In the absence of OVA, 10 ng LPS alone caused a
slight increase of neutrophils in BALF, but 1 ng LPS was
less effective than10 ng LPS. However in the presence of
H-ASD, 10 ng LPS caused a marked increase of neutro-
phils in BALF along with the proinflammatory mediators
IL-12, RANTES, MCP-1, IL-6, and TNF-α. Pathologically,
10 ng LPS caused moderate bronchitis and alveolitis, sug-
gesting that H-ASD aggravates LPS-induced lung inflam-
mation via the increased proinflammatory mediators.
In the presence of OVA, LPS at the levels of 1 ng and
10 ng caused a slight increase of eosinophils (Figure 2).
LPS at the level of 10 ng caused a moderate increase of
neutrophils along with proinflammatory mediators IL-12,
KC, RANTES, MCP-1, IL-6 and TNF-α in BALF, but the
induction of Th2 cytokines IL-5, IL-13 occurred only at
trace levels, suggesting that OVA + LPS 10 does not serve
to induce strong Th2 responses.
In the presence of H-ASD + OVA, LPS at the levels of
1 ng and 10 ng increased neutrophil and eosinophi
numbers. In particular, 10 ng LPS increased more pro-
inflammatory cytokines (IL-1β, IL-6, IL-12, IL-17A, TNF-α)
and chemokines (RANTES, MIP-1α, KC, MCP-1, Eotaxin,
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The pathological changes—eosinophil recruitment in the
submucosa of the airway along with proliferation of goblet
cells in the bronchial epithelium in the airway— and Th2
cytokines IL-5/IL-13 induced by 1 ng LPS were more re-
markable than 10 ng LPS, suggesting that co-exposure to
H-ASD and LPS, particularly 1 ng LPS, can lead to Th2
responses to inhaled OVA more than 10 ng LPS can. The
Th2 cytokines together with increased eosinophil-relevant
chemokines eotaxin and MCP-3 aggravated eosinophilic
lung inflammation in the present study.
Overall, H-ASD played an important role in the exacer-
bation of pathological changes (Figure 3). Eosinophils are
reportedly implicated in tissue destruction in allergic
asthma [24]. Because toxic eosinophil–derived proteins,
such as major basic proteins, cause bronchial mucosal
damage in asthmatic airways, they may exacerbate the
symptoms of asthma [25]. IL-5 generated from Th2 cells
attracts and activates eosinophils, which are implicated in
tissue destruction in allergic asthma [26]. IL-13 has been
shown to stimulate B cells and subsequently produce anti-
gen specific antibodies [27]. It also promotes mucous se-
cretion and the production of mucous cells, such as goblet
cells, in the bronchial epithelium [28]. Therefore, airway
injury resulting from co-treatment may be due to exacer-
bation of eosinophilic airway-inflammation. This allergic
airway inflammation recruits not only eosinophils, but also
neutrophils. There is a report that IL-17A contributes to
neutrophil infiltration in airway inflammation in allergic
asthma [29].
Toll like receptors (TLRs) are pattern recognition recep-
tors (PRRs) that play an essential role in animal immunity
[30]. TLR4 is well known as a receptor for LPS. Previousin vivo findings indicate that low levels of LPS can cause
TLR4-dependent Th2 responses to OVA [16,31]. Low
levels of LPS activate Th2 responses to OVA through
the adaptor protein myeloid differentiation factor 88
(MyD88) [32]. In this animal study, the induction of
pro-inflammatory molecules in BALF may be a TLR4-
dependent signaling pathway, but not a TLR2 pathway,
because there is no contamination of TLR2-ligands in
LPS from as a result of the in vitro experiment. In the
presence of OVA, Th2 responses to 1 ng and 10 ng LPS
were defective. Interestingly, in the presence of OVA
and H-ASD, the two doses of LPS, especially the 1 ng
dose markedly enhanced Th2 responses. This may have
been caused by a TLR4-dependent signaling pathway
through MyD88. In both the presence and absence of
OVA, low dose LPS caused no response in the form of
induction of Th1 cytokine IFN-γ, suggesting that low
doses of LPS lack the potency for leading to a Th1 re-
sponse. Interferon γ reportedly inhibits the development
of secondary allergic responses in mice [33]. Therefore, we
speculate that the lack of IFN-γ skews lung inflammation
in a Th2 direction. However, the present study did not
provide sufficient evidence to explain the role of H-ASD
in enhancement of Th2 responses. Our previous in vitro
study has shown that H-ASD treatment in the presence of
LPS dose-dependently enhanced the production of inflam-
matory mediators by BMDMs from ICR mice [18]. In this
in vivo study, co-exposure to H-ASD and LPS enhanced
neutrophilic inflammation and the production of inflam-
matory mediators in BALF. An increase in antigen pre-
senting cells, such as macrophages, caused by H-ASD
(Figure 2) and the activation of the TLR4-signaling
pathway leading to inflammatory cytokine production
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related to Th2. Although the pathway leading to Th2
activation is unclear in this study, it is clear that H-ASD
has potential to elicit a weak reaction by adding a low
dose of LPS. Similar potential of H-ASD has been ob-
served in lung inflammation caused by Gram negative
bacteria, Klebsiella Pneumoniae [34] and fungi, Bjerkan-
dera adusta [35].
On the other hand, in the presence of H-ASD and OVA,
low doses of LPS caused the production of OVA-specific
IgE and IgG1 in serum. It seems that these increases are
being interlocked with activation of Th2 response caused
by these mixtures. H-ASD used contains 14.3% Al2O3. Al-
though aluminum adjuvant is well known, Al2O3 may not
contribute to the adjuvant effect. The adjuvant effect of
Al2O3 particle on their immunoglobulin productions
was not detected in our previous study [36]. However,
SiO2 is a possible adjuvant. Allergen-specific antibodies
may contribute to the occurrence of inflammatory cell
accumulation after an allergen challenge via IgE-mediated
degranulation of mast cells [37]. Antigen-specific IgG1
can cause degranulation via an Fcg RII receptor on the eo-
sinophil’s surface [38]. Therefore, antibodies may play an
important role in the aggravation of lung eosinophilia
caused by H-ASD + OVA + LPS.
Conclusions
This study demonstrates that LPS contamination in ASD
aggravates allergic lung inflammation in the presence of
OVA and H-ASD. The aggravation of the allergic lung
inflammation by LPS may be caused through the TLR4-
dependent signaling pathway. The results of the current
study indicate that the exposure to ASD with LPS may
be a significant risk factor for adult and child asthma.
The hazardous effects of mineral dust and biogenic
agents on human respiratory disease are an increasing
public concern. Atmospheric exposure to bacteria, fungi
and virus, and silica-carrying particulate matters may
influence human respiratory health on a world-wide
scale.
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